Baird Financial Group Inc. Has $37.76 Million Stake in Lam Research Corporation $LRCX

Key Points

• Baird Financial Group Inc. reduced its stake in Lam Research Corporation by 4.4%, selling 23,730 shares, which left them with 519,350 shares valued at $37.76 million.
• Lam Research's stock performance has been positive, with several analysts raising their target prices, leading to a consensus rating of "Moderate Buy" and an average target price of $107.30.
• The company has announced an increase in its quarterly dividend from $0.23 to $0.26 per share, representing an annualized yield of 1.0%.

Baird Financial Group Inc. lowered its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 4.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 519,350 shares of the semiconductor company's stock after selling 23,730 shares during the quarter. Baird Financial Group Inc.'s holdings in Lam Research were worth $37,757,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Activest Wealth Management lifted its stake in Lam Research by 65.5% in the first quarter. Activest Wealth Management now owns 917 shares of the semiconductor company's stock valued at $67,000 after acquiring an additional 363 shares during the last quarter. Vident Advisory LLC lifted its stake in Lam Research by 16.2% in the first quarter. Vident Advisory LLC now owns 41,710 shares of the semiconductor company's stock valued at $3,032,000 after acquiring an additional 5,806 shares during the last quarter. Kodai Capital Management LP acquired a new stake in Lam Research in the first quarter valued at $36,785,000. Evergreen Capital Management LLC raised its position in shares of Lam Research by 63.1% in the first quarter. Evergreen Capital Management LLC now owns 13,263 shares of the semiconductor company's stock valued at $967,000 after purchasing an additional 5,130 shares during the period. Finally, Canada Pension Plan Investment Board raised its position in shares of Lam Research by 66.4% in the first quarter. Canada Pension Plan Investment Board now owns 2,699,143 shares of the semiconductor company's stock valued at $196,228,000 after purchasing an additional 1,077,487 shares during the period. Institutional investors and hedge funds own 84.61% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on LRCX shares. UBS Group increased their price objective on shares of Lam Research from $95.00 to $120.00 and gave the company a "buy" rating in a research report on Monday, July 21st. Mizuho increased their price objective on shares of Lam Research from $115.00 to $120.00 and gave the company an "outperform" rating in a research report on Friday, August 1st. The Goldman Sachs Group started coverage on shares of Lam Research in a research report on Thursday, July 10th. They issued a "buy" rating and a $115.00 price objective on the stock. Erste Group Bank started coverage on shares of Lam Research in a research report on Thursday, August 14th. They issued a "buy" rating on the stock. Finally, TD Cowen increased their price objective on shares of Lam Research from $100.00 to $125.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $107.22.

Lam Research Stock Performance

NASDAQ:LRCX traded up $2.53 during mid-day trading on Friday, reaching $102.95. 8,138,513 shares of the company's stock were exchanged, compared to its average volume of 10,784,377. Lam Research Corporation has a one year low of $56.32 and a one year high of $108.02. The firm has a market capitalization of $130.30 billion, a PE ratio of 24.75, a price-to-earnings-growth ratio of 1.29 and a beta of 1.76. The business's fifty day simple moving average is $99.87 and its two-hundred day simple moving average is $85.83. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. During the same period last year, the firm earned $1.03 earnings per share. Lam Research's revenue for the quarter was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, September 24th. This is a positive change from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a yield of 1.0%. Lam Research's dividend payout ratio is currently 22.12%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.